Pharma’s race for a ‘pink viagra’ finally has a winner, and the promises for it are grand. Osphena, as the recently FDA-approved drug is called, is the newest answer for painful sex. The drug’s creator, pharmaceutical company Shionogi, Inc., is particularly interested in the more than 64 million U.S. women who have hit menopause, half of whom, it claims, could use the drug. In theory, that’s a lot of women who could be having a lot better sex, and soon.